GDC-0449 (Vismodegib) - Hedgehog Antagonist. CAS# 879085-55-9 094 but not H3K56ac as revealed

but not H3K56ac as revealed by western blot analysis

which continued to grow

InChi: InChI=1S/C40H50N8O6

Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells

Studies showed that it has more potent activity than the recombinant Hh protein in activating Smo and hedgehog pathway

GDC-0449 (Vismodegib) - Hedgehog Antagonist. CAS# 879085-55-9 094 but not H3K56ac as revealedVismodegib (GDC 0449), CAS No. 879085 55 9, is a potent and specific hedgehog pathway inhibitor with an IC50 of 3 nM. It has been approved by FDA to treat BCC, and also in multiple clinical trials to treat advanced solid tumors. It blocks the activities of the Hedgehog ligand cell surface receptors PTCH and or SMO and suppressing Hedgehog signaling. It prevents multiple ATP binding cassette (ABC) transporters. GDC 0449 also exhibited efficacy in